Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 102.9B | 121.3B | 102.8B | 95.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 2.3B | 1.9B | 3.4B | 3.0B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 112.0B | 105.5B | 98.2B | 93.7B |
| Tax provision | 22.2B | 22.0B | 20.6B | 21.5B |
| Net income | 89.8B | 83.6B | 77.6B | 72.1B |
| Basic EPS | 20.8 | — | 17.7 | 16.1 |
| Diluted EPS | 20.8 | — | 17.7 | 16.1 |
| Basic average shares | 3.3B | — | 3.3B | 3.3B |
| Diluted average shares | 3.3B | — | 3.3B | 3.3B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -21.2B | -20.4B | -19.3B | -19.1B |
| Preferred stock dividends | — | — | — | — |